Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS Author FAQs
    • COVID-19 submission information
  • Alerts
  • Subscriptions

Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19

Rahul Kumar, Michael H. Lee, Claudia Mickael, Biruk Kassa, Qadar Pasha, Rubin Tuder, Brian Graham
ERJ Open Research 2020 6: 00405-2020; DOI: 10.1183/23120541.00405-2020
Rahul Kumar
1Dept of Medicine, Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rahul Kumar
  • For correspondence: rahul.kumar2@ucsf.edu
Michael H. Lee
1Dept of Medicine, Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Mickael
2Dept of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Biruk Kassa
1Dept of Medicine, Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qadar Pasha
3Functional Genomics Unit, CSIR-Institute of Genomics and Integrative Biology, Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rubin Tuder
2Dept of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Graham
1Dept of Medicine, Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brian Graham
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 6 no. 4
DOI 
https://doi.org/10.1183/23120541.00405-2020

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received June 20, 2020
  • Accepted October 27, 2020
  • Published online December 7, 2020.

Article Versions

  • previous version (November 6, 2020 - 08:46).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©ERS 2020 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. Rahul Kumar1⇑,
  2. Michael H. Lee1,
  3. Claudia Mickael2,
  4. Biruk Kassa1,
  5. Qadar Pasha3,
  6. Rubin Tuder2 and
  7. Brian Graham1
  1. 1Dept of Medicine, Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA
  2. 2Dept of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
  3. 3Functional Genomics Unit, CSIR-Institute of Genomics and Integrative Biology, Delhi, India
  1. Rahul Kumar, Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA 94110, USA. E-mail: rahul.kumar2{at}ucsf.edu
View Full Text

Funding

  • Pulmonary Hypertension Association

  • National Heart, Lung, and Blood Institute

    P01HL014985; P01HL152961; R01HL135872
  • American Heart Association

    19CDA34730030

Article usage

Article usage: November 2020 to December 2020

AbstractFullPdf
Nov 2020847950
Dec 202087384198

Altmetrics

PreviousNext
Back to top
Vol 6 Issue 4 Table of Contents
ERJ Open Research: 6 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
Rahul Kumar, Michael H. Lee, Claudia Mickael, Biruk Kassa, Qadar Pasha, Rubin Tuder, Brian Graham
ERJ Open Research Oct 2020, 6 (4) 00405-2020; DOI: 10.1183/23120541.00405-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19
Rahul Kumar, Michael H. Lee, Claudia Mickael, Biruk Kassa, Qadar Pasha, Rubin Tuder, Brian Graham
ERJ Open Research Oct 2020, 6 (4) 00405-2020; DOI: 10.1183/23120541.00405-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Origin of SARS-COV-2 and mode of transmission to humans
    • ACE2: a portal of entry for SARS-CoV-2
    • Role of animal models in elucidating the pathogenesis of COVID-19
    • The pulmonary pathophysiology of COVID-19
    • Potential molecular and biochemical therapeutic targets in the host
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Do probiotics help prevent VAP in critically ill patients?
  • Sex disparities in cystic fibrosis
  • Severe asthma
Show more Reviews

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2021 by the European Respiratory Society